• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BOT
Click for more information
0.00% 31.5¢

BOTANIX PHARMACEUTICALS LTD - Charts / Financials

Market Cap $707.4M  ! watchlist Created with Sketch. Add to my watchlist

Botanix Pharmaceuticals Limited is an Australia-based dermatology company. The Company is... Botanix Pharmaceuticals Limited is an Australia-based dermatology company. The Company is engaged in the development and commercialization of treatments for common skin diseases and infections. Its lead product is Sofpironium Bromide, for the treatment of primary axillary hyperhidrosis. It also has a pipeline of other products in late-stage clinical studies for the treatment of moderate to severe rosacea, dermatitis, and acne respectively. It also developing a topical antimicrobial product for the eradication of bacteria on the skin surface, initially in patients who are undergoing hemodialysis. Its BTX1503 product is a transdermal gel formulation for the treatment of serious acne in adults and teenagers. Its BTX1702 product for the treatment of papulopustular rosacea. Its BTX 1204A canine study in Australia and New Zealand for atopic dermatitis. Its BTX1801 is an antimicrobial gel focused on targeting Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 15.59pm 21/11/2024 (20 minute delay) ?
Day
Open 31.5¢   Day High 32.5¢   Day Low 30.5¢
Daily Volume 4765488
Bids   Sellers
Number Price Volume   Number Price Volume
4 31.0¢ 189068   6 32.0¢ 535424

Directors & Senior Management

Mr. Vincent P. Ippolito Executive Chairman of the Board, President
Mr. Howie McKibbon Chief Executive Officer
Mr. Graeme Morissey Chief Financial Officer
Dr. William Bosch Executive Director
Mr. Matthew Callahan Executive Director
Ms. Susan Park Company Secretary
Mr. Daniel Sharp Non-Executive Director
Dr. Stewart James Washer Non-Executive Director

Data source: Refinitiv

(20min delay)
Last
31.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $707.4M
Open High Low Value Volume
31.5¢ 32.5¢ 30.5¢ $1.502M 4.765M

Buyers (Bids)

No. Vol. Price($)
4 189068 31.0¢
 

Sellers (Offers)

Price($) Vol. No.
32.0¢ 535424 6
View Market Depth
Last trade - 16.10pm 21/11/2024 (20 minute delay) ?
Last
31.5¢ 		  Change
0.000 ( 0.48 %)
Open High Low Volume
32.0¢ 32.5¢ 30.8¢ 1813559
Last updated 15.59pm 21/11/2024 ?

Top Stories

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Alcidion inks deal with Vic health provider Peninsula for use of Miya Precision tech Alcidion Group Ltd has signed a contract worth $3.7M to enable use of its Miya Precision platform by users of Peninsula Health entities
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.